LEXARIA BIOSCIENCE CORP (LEXX:NASDAQ)
$0.91 0.0051 (0.5636%)
Analysed LEXARIA BIOSCIENCE CORP (LEXX:NASDAQ) News Sources
Lexaria Applauds Eli Lilly's Foundayo(TM) Drug Approval
07-04-2026
yahoo.com
Lexaria to Begin New Human Clinical Study in GLP-1
01-04-2026
yahoo.com
Lexaria's Robust Patent Portfolio Continues to Grow
26-03-2026
yahoo.com
Lexaria's Oral GLP-1 Drug Strategy Validated by Industry
24-03-2026
yahoo.com
Lexaria Announces New R&D Plans for 2026
04-03-2026
yahoo.com
LEXX: First Quarter Results
10-02-2026
yahoo.com
Lexaria Announces Positive Final Results From Human Pilot Study #5
05-02-2026
yahoo.com
Lexaria Awarded Six Additional Patents
22-01-2026
yahoo.com
Lexaria Releases Annual Letter from the CEO
12-01-2026
yahoo.com
Lexaria releases additional results from Phase 1b study GLP-1-H24-4
31-12-2025
yahoo.com
What is the current price of LEXARIA BIOSCIENCE CORP (LEXX:NASDAQ)?
The current price of LEXARIA BIOSCIENCE CORP (LEXX:NASDAQ) is $0.91.
LEXARIA BIOSCIENCE CORP (LEXX:NASDAQ) absolute price change since previous trading day?
The absolute price change of LEXARIA BIOSCIENCE CORP (LEXX:NASDAQ) since the previous trading day is $0.0051.
LEXARIA BIOSCIENCE CORP (LEXX:NASDAQ) percentage price change since previous trading day?
The percentage price change of LEXARIA BIOSCIENCE CORP (LEXX:NASDAQ) since the previous trading day is 0.5636%.
What is the most recent average sentiment score for LEXARIA BIOSCIENCE CORP (LEXX:NASDAQ)?
The most recent average sentiment score for LEXARIA BIOSCIENCE CORP (LEXX:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for LEXARIA BIOSCIENCE CORP (LEXX:NASDAQ)?
The most recent sentiment for LEXARIA BIOSCIENCE CORP (LEXX:NASDAQ) is .
SEC-8K** Filing Available For LEXARIA BIOSCIENCE CORP (LEXX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.